Home Defining the Period of Recovery of the Glucose Concentration after Its Local Perturbation by the Implantation of a Miniature Sensor
Article
Licensed
Unlicensed Requires Authentication

Defining the Period of Recovery of the Glucose Concentration after Its Local Perturbation by the Implantation of a Miniature Sensor

  • Ting Chen , David W. Schmidtke and Adam Heller
Published/Copyright: June 1, 2005
Become an author with De Gruyter Brill
Clinical Chemistry and Laboratory Medicine (CCLM)
From the journal Volume 40 Issue 8

Abstract

At the wound caused by implanting a subcutaneous glucose sensor, the concentration of glucose differs transiently from that in the subcutaneous fluid near non-wounded skin. The period of recovery differs for different wounds and is difficult to predict. A diabetic patient implanting a subcutaneous sensor needs to know whether the transient difference subsided sufficiently for the sensor readings and the sensor's in vivo calibration to be valid. The miniature amperometric glucose sensor has a compound membrane including a layer of glucose oxidase the reaction centers of which are electrically connected to the electrode through a redox polymer; layers excluding interferents and poisons of the electrocatalytic oxidation of glucose; and a layer reducing fouling by components of the biological fluids. We show that the sensor maintains its in vitro sensitivity after its implantation for four hours in the jugular vein and in the peritoneal fluid of the rat. For a diabetic patient who implants the sensor the four-hour period is long enough for the insertion-trauma-caused local perturbation of the glucose concentration to subside and to safely rely on the readings of the implanted sensor.

:
Published Online: 2005-06-01
Published in Print: 2002-08-26

Copyright © 2002 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. SIBioC 2002 - 34th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology, Rimini, Italy, 17-20 September 2002
  2. Santorini Biologie Prospective Conference 2002 From Genetic Variations to Risk Prediction and Pharmacogenomics Santorini, Greece, 25-28 September 2002
  3. CCLM Special Issue on Diabetes Mellitus - Call for Papers
  4. Pathophysiological and Clinical Relevance of Circulating Levels of Cardiac Natriuretic Hormones: Are They Merely Markers of Cardiac Disease?
  5. Comparative Measurement of N-Terminal Pro-Brain Natriuretic Peptide and Brain Natriuretic Peptide in Ambulatory Patients with Heart Failure
  6. Tumor Necrosis Factor-α-Induced Accumulation of Tumor Suppressor Protein p53 and Cyclin-dependent Protein Kinase Inhibitory Protein p21 Is Inhibited by Insulin in ME-180S Cells
  7. Inflammatory Response to Coronary Stent Implantation in Patients with Unstable Angina
  8. Immature Granulocyte Count after Liver Transplantation
  9. An Ideal Substrate for the Measurement of Pancreatic Amylase?
  10. Defining the Period of Recovery of the Glucose Concentration after Its Local Perturbation by the Implantation of a Miniature Sensor
  11. Measurement of Serum β-Crosslaps Is Influenced by Proteolytic Conditions
  12. Quantitative Determination of Faecal Fatty Acids and Triglycerides by Fourier Transform Infrared Analysis with a Sodium Chloride Transmission Flow Cell
  13. Rapid Identification of Atypical Variant of Plasma Butyrylcholinesterase by PCR
  14. Determination of Nitrite Plus Nitrate and Malondialdehyde in Human Plasma: Analytical Performance and the Effect of Smoking and Exercise
  15. Iron Status in Black Persons Is Not Influenced by Haptoglobin Polymorphism
  16. Molecular Characterization of Glucose-6-Phosphate Dehydrogenase Deficiency in the Eastern Province of Saudi Arabia
  17. Comparison of Urine Cell Characteristics by Flow Cytometry and Cytology in Patients Suspected of Having Bladder Cancer
  18. Clinical Validation of a Fully Automated 17β-Estradiol and Progesterone Assay (VIDAS®) for Use in Monitoring Assisted Reproduction Treatment
  19. Evaluation of a Commercially Available Serologic Assay for Antibodies against Tuberculosis-associated Glycolipid Antigen
  20. Evaluation of Two Modified Cardiac Troponin I Enzyme Immunoassays
  21. Evaluation of Denka-Seiken Turbidimetric High-Sensitivity C-Reactive Protein Assay
  22. Amiodarone and Desethylamiodarone Bind to Barrier Gels in Serum Separator Blood Collection Tubes
  23. A Novel Explanation for Low Alanine Aminotransferase Activity in Human Serum Caused by IgG Inhibitor
  24. Serum Total Antioxidant Status Is Higher in Postmenopausal Women and after Estrogen Replacement Therapy
  25. Immunoturbidimetric Assay for Serum Cystatin C Using the Cobas Fara Analyzer
  26. Meetings and Awards
Downloaded on 19.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2002.135/html
Scroll to top button